SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:liu-36168"
 

Sökning: onr:"swepub:oai:DiVA.org:liu-36168" > Requirement for CDK...

  • Yu, QunyanDepartment of Cancer Biology, Dana-Farber Cancer Institute, and Department of Pathology, Harvard Medical School, Boston, Massachusetts (författare)

Requirement for CDK4 kinase function in breast cancer

  • Artikel/kapitelEngelska2006

Förlag, utgivningsår, omfång ...

  • Elsevier BV,2006
  • printrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:liu-36168
  • https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-36168URI
  • https://doi.org/10.1016/j.ccr.2005.12.012DOI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • Cyclin D1 is overexpressed in the majority of human breast cancers. We previously found that mice lacking cyclin D1 are resistant to mammary carcinomas triggered by the ErbB-2 oncogene. In this study, we investigated which function of cyclin D1 is required for ErbB-2-driven mammary oncogenesis. We report that the ability of cyclin D1 to activate cyclin-dependent kinase CDK4 underlies the critical role for cyclin D1 in breast cancer formation. We also found that the continued presence of CDK4-associated kinase activity is required to maintain breast tumorigenesis. We analyzed primary human breast cancers and found high cyclin D1 levels in a subset (∼25%) of ErbB-2-overexpressing tumors. We propose that this subset of breast cancer patients might benefit from inhibiting CDK4 kinase.

Ämnesord och genrebeteckningar

  • MEDICINE
  • MEDICIN

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Sicinska, EwaDepartment of Cancer Biology, Dana-Farber Cancer Institute, and Department of Pathology, Harvard Medical School, Boston, Massachusetts (författare)
  • Geng, YanDepartment of Cancer Biology, Dana-Farber Cancer Institute, and Department of Pathology, Harvard Medical School, Boston, Massachusetts (författare)
  • Ahnström, Marie,1976-Linköpings universitet,Onkologi,Hälsouniversitetet(Swepub:liu)marah62 (författare)
  • Zagozdzon, AgnieszkaDepartment of Cancer Biology, Dana-Farber Cancer Institute, and Department of Pathology, Harvard Medical School, Boston, Massachusetts (författare)
  • Kong, YinxinDepartment of Cancer Biology, Dana-Farber Cancer Institute, and Department of Pathology, Harvard Medical School, Boston, Massachusetts (författare)
  • Gardner, HumphreyDepartment of Research Pathology, Biogen Idec, Cambridge, Massachusetts (författare)
  • Kiyokawa, HiroakiDepartment of Molecular Pharmacology and Biochemical Chemistry, Northwestern University, Chicago, Illinois (författare)
  • Harris, Lyndsay NDepartment of Cancer Biology, Dana-Farber Cancer Institute, and Department of Pathology, Harvard Medical School, Boston, Massachusetts and Department of Medical Oncology, Dana-Farber Cancer Institute, and Brigham and Women's Hospital, Boston, Massachusetts (författare)
  • Stål, Olle,1952-Linköpings universitet,Onkologi,Hälsouniversitetet(Swepub:liu)ollst87 (författare)
  • Sicinski, PiotrDepartment of Cancer Biology, Dana-Farber Cancer Institute, and Department of Pathology, Harvard Medical School, Boston, Massachusetts (författare)
  • Department of Cancer Biology, Dana-Farber Cancer Institute, and Department of Pathology, Harvard Medical School, Boston, MassachusettsOnkologi (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Cancer Cell: Elsevier BV9:1, s. 23-321535-61081878-3686

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy